Literature DB >> 2621458

An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22.

J P Figueroa1, D Ashley, D King, B Hull.   

Abstract

An outbreak of acute flaccid paralysis in Jamaica in 1986 associated with echovirus type 22 is described. Six patients aged 1 to 27 years developed acute onset of severe flaccid paralysis, with inability to walk. Three cases had facial weakness, four required intensive care with assisted ventilation, and two died. Echovirus type 22 was isolated from the stool of two patients who showed a significant increase in antibody titre. Echovirus type 22 was also isolated from the stool of another patient who had aseptic meningitis without any neurological deficit. There was no evidence of poliovirus infection in any of these patients, most of whom were fully immunized. Of the four surviving cases with flaccid paralysis, three had residual weakness in their lower limbs and walked with an abnormal gait 3 years after the acute paralytic attack. This is the first report in the literature of acute flaccid paralysis associated with type 22 echovirus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621458     DOI: 10.1002/jmv.1890290418

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  30 in total

1.  Cap-binding complex protein p220 is not cleaved during echovirus 22 replication in HeLa cells.

Authors:  B G Coller; S M Tracy; D Etchison
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains.

Authors:  Mohammed Al-Sunaidi; Cigdem H Williams; Pamela J Hughes; David P Schnurr; Glyn Stanway
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

Review 3.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

5.  Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors.

Authors:  K Triantafilou; M Triantafilou; Y Takada; N Fernandez
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  A 5-year study of human parechoviruses in children living in bad sanitation conditions and non-polio acute flaccid paralysis children from Greece.

Authors:  Karageorgou Ioulia; Pogka Vasiliki; Labropoulou Stavroula; Angelakis Emmanouil; Mentis Andreas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-16       Impact factor: 3.267

Review 7.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Diversity of human parechoviruses isolated from stool samples collected from Thai children with acute gastroenteritis.

Authors:  Ngan Thi Kim Pham; Quang Duy Trinh; Pattara Khamrin; Niwat Maneekarn; Hideaki Shimizu; Shoko Okitsu; Masashi Mizuguchi; Hiroshi Ushijima
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

9.  Development of a serological assay based on a synthetic peptide selected from the VP0 capsid protein for detection of human parechoviruses.

Authors:  Yacine Abed; Dana Wolf; Ron Dagan; Guy Boivin
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

10.  Genomic characterization of novel human parechovirus type.

Authors:  Linlin Li; Joseph Victoria; Amit Kapoor; Asif Naeem; Shahzad Shaukat; Salmaan Sharif; Muhammad Masroor Alam; Mehar Angez; Sohail Zahoor Zaidi; Eric Delwart
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.